Examkin

Question

Difficulty: HardDepressive Disorders

During a follow-up visit at the university health center, a 24-year-old graduate student reports persistent feelings of profound sadness and lack of motivation that have severely impacted her studies over the past eight weeks. She mentions sleeping 11 to 13 hours daily, a recent 5-kg (11-lb) weight gain, and a sensation that her limbs are "made of lead." Two weeks prior to this visit, a physician prescribed citalopram. The patient reveals she abruptly stopped taking it three days ago due to mild nausea and a belief that "the pills were completely useless." While exploring her psychiatric history, she mentions a distinct 2-day period during her freshman year when she felt "euphoric and full of energy," requiring only a few hours of sleep while celebrating the end of final exams with friends. Her mood returned to baseline shortly after the weekend. She currently takes no medications and uses no illicit substances. Which of the following is the most appropriate next step in the management of this patient?

  1. Reinitiate citalopram and advise that therapeutic benefits typically require four to six weeksAnswer
  2. B
    Discontinue citalopram permanently and initiate lurasidone
  3. C
    Initiate phenelzine immediately to specifically target the atypical depressive features
  4. D
    Switch to bupropion to address her excessive sleep and weight gain
  5. E
    Increase the dose of citalopram to achieve a faster therapeutic response

Answer

The correct approach is to reinitiate citalopram and advise the patient that therapeutic benefits typically require four to six weeks.
The patient is experiencing a major depressive episode with atypical features (hypersomnia, hyperphagia, leaden paralysis). Her 2-day period of euphoria following exams was a normal situational response, not a hypomanic episode (which explicitly requires a duration of at least 4 consecutive days). Her lack of response to citalopram is due to premature discontinuation, as she only took the medication for approximately 11 days. Antidepressants typically require an adequate trial of 4 to 6 weeks to achieve clinical efficacy. Mild gastrointestinal side effects like nausea are common early in SSRI therapy and usually resolve spontaneously. Educating the patient on this timeline and reinitiating the medication is the most appropriate next step.

Step-by-Step Solution

1
Analyze the patient's current clinical presentation.
The patient exhibits a 2-month history of depressed mood, hypersomnia, hyperphagia, and leaden paralysis, which firmly establishes a diagnosis of a Major Depressive Episode with atypical features.
Establishing the current syndrome is necessary to determine baseline treatment requirements.
2
Evaluate the psychiatric history for prior mood episodes to rule out bipolar disorder.
The patient experienced a 2-day period of euphoria and decreased need for sleep after final exams. This represents a normal, situational celebratory response and falls short of the strict 4-day minimum duration criteria required for a true hypomanic episode.
Differentiating unipolar depression from bipolar depression is critical, as SSRI monotherapy is safe for unipolar depression but contraindicated in bipolar disorder.
3
Assess the adequacy of the current psychopharmacological trial.
The patient took citalopram for approximately 11 days before stopping due to perceived inefficacy and mild nausea. An adequate antidepressant trial requires 4 to 6 weeks at a therapeutic dose.
Identifying premature drug discontinuation dictates that the provider should educate the patient rather than prematurely changing the medication class or dose.
4
Determine the safest and most appropriate next step in management.
Reinitiating citalopram while educating the patient on the delayed onset of action and the typically transient nature of mild gastrointestinal side effects is the standard of care.
This prevents unnecessary polypharmacy, avoids dangerous drug interactions (like serotonin syndrome with MAOIs), and ensures an evidence-based treatment timeline is followed.

Key Concept

An adequate trial of an antidepressant requires 4 to 6 weeks at a therapeutic dose; mild early side effects should be managed with reassurance, and a thorough history must confirm that prior mood elevations were normal situational responses rather than true hypomania.
Estimated Time:1m 30s
Rate this question

Topics

Depressive Disorders

More questions from this topic